194 related articles for article (PubMed ID: 17638738)
1. Cutaneous T-cell lymphoma epidemiology: patients providing the power.
Lessin SR
Arch Dermatol; 2007 Jul; 143(7):916-8. PubMed ID: 17638738
[No Abstract] [Full Text] [Related]
2. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
Arai E; Katayama I; Ishihara K
Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
[TBL] [Abstract][Full Text] [Related]
4. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and clinical manifestations of cutaneous T-cell lymphoma.
Koh HK; Charif M; Weinstock MA
Hematol Oncol Clin North Am; 1995 Oct; 9(5):943-60. PubMed ID: 8522490
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous T-cell lymphoma (mycosis fungoides).
Lorincz AL
Lancet; 1996 Mar; 347(9005):871-6. PubMed ID: 8622396
[No Abstract] [Full Text] [Related]
7. Incidence of primary cutaneous T-cell lymphoma in Norway.
Saunes M; Nilsen TI; Johannesen TB
Br J Dermatol; 2009 Feb; 160(2):376-9. PubMed ID: 18808419
[TBL] [Abstract][Full Text] [Related]
8. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
[TBL] [Abstract][Full Text] [Related]
9. Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States.
Dores GM; Curtis RE; Anderson WF; Demierre MF
Arch Dermatol; 2008 Mar; 144(3):413-4. PubMed ID: 18347305
[No Abstract] [Full Text] [Related]
10. Prevalence and severity of pruritus in cutaneous T cell lymphoma.
Vij A; Duvic M
Int J Dermatol; 2012 Aug; 51(8):930-4. PubMed ID: 22788808
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in the risk of secondary malignancies in patients with mycosis fungoides and Sézary syndrome.
Almukhtar R; Gill F; Soine R; McBurney E
J Am Acad Dermatol; 2020 Aug; 83(2):647-648. PubMed ID: 31809823
[No Abstract] [Full Text] [Related]
12. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of primary cutaneous lymphomas in Tehran, Iran (1998-2004).
Manuchehri HM; Rakhshan M
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):758-60. PubMed ID: 16836523
[No Abstract] [Full Text] [Related]
14. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
Tan ES; Tang MB; Tan SH
Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous lymphomas.
Smith BD; Wilson LD
Semin Radiat Oncol; 2007 Jul; 17(3):158-68. PubMed ID: 17591562
[TBL] [Abstract][Full Text] [Related]
16. Is bone marrow biopsy necessary in patients with mycosis fungoides and Sézary syndrome? A histological and molecular study at diagnosis and during follow-up.
Beylot-Barry M; Parrens M; Delaunay M; Thiebault R; Vergier B; DeMascarel A; Dubus P; Beylot C; Merlio JP
Br J Dermatol; 2005 Jun; 152(6):1378-9. PubMed ID: 15949023
[No Abstract] [Full Text] [Related]
17. Cutaneous T-cell lymphoma: overview and nursing perspectives.
McCann SA
Nurs Clin North Am; 2007 Sep; 42(3):421-55, vi-vii. PubMed ID: 17825663
[TBL] [Abstract][Full Text] [Related]
18. Relative frequency of various forms of primary cutaneous lymphomas.
Zackheim HS; Vonderheid EC; Ramsay DL; LeBoit PE; Rothfleisch J; Kashani-Sabet M
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):793-6. PubMed ID: 11050582
[TBL] [Abstract][Full Text] [Related]
19. Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.
Introcaso CE; Micaily B; Richardson SK; Junkins-Hopkins JM; Yoon JS; Kim EJ; Vittorio CC; Rook AH
J Am Acad Dermatol; 2008 Apr; 58(4):592-5. PubMed ID: 18249469
[TBL] [Abstract][Full Text] [Related]
20. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
